BamSEC and AlphaSense Join Forces
Learn More

Cellectar Biosciences Inc.

NASDAQ: CLRB    
Share price (12/27/24): $0.31    
Market cap (12/27/24): $12.7 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 1 page Amendment to Second Amended and Restated Certificate of Incorporation of Cellectar Biosciences, Inc
12/34/56
EX-3.3
from 8-K 17 pages Series E Convertible Voting Preferred Stock
12/34/56
EX-3.2
from 8-K 1 page Amendment No. I to Certificate of Designation of Series D Convertible Preferred Stock of Cellectar Biosciences, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Elimination of Cellectar Biosciences, Inc
12/34/56
EX-3.1
from 8-K 18 pages Amended and Restated By-Laws of Cellectar Biosciences, Inc. a Delaware Corporation
12/34/56
EX-3.1
from 8-K 1 page Amendment to Second Amended and Restated Certificate of Incorporation of Cellectar Biosciences, Inc
12/34/56
EX-3.1
from 10-Q 1 page State of Delaware Certificate of Correction
12/34/56
EX-3.2
from 10-Q 2 pages State of Delaware Certificate of Correction
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Second Amended and Restated Certificate of Incorporation of Cellectar Biosciences, Inc
12/34/56
EX-3.1
from 8-K 19 pages Terms of Preferred Stock
12/34/56
EX-3.11
from S-1/A 21 pages Cellectar Biosciences, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Second Amended and Restated Certificate of Incorporation of Cellectar Biosciences, Inc
12/34/56
EX-3.1
from 8-K 18 pages Cellectar Biosciences, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.2
from 8-K 1 page Certificate of Amendment of Second Amended and Restated Certificate of Incorporation of Cellectar Biosciences, Inc
12/34/56
EX-3.7
from S-1/A 20 pages Cellectar Biosciences, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to Second Amended and Restated Certificate of Incorporation of Cellectar Biosciences, Inc
12/34/56
EX-3.2
from 8-K 3 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Cellectar Biosciences, Inc
12/34/56
EX-3.1
from 8-K 3 pages Certificate of Ownership and Merger of Cellectar Biosciences, Inc. With and Into Novelos Therapeutics, Inc. Pursuant to Section 253 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.3
from S-1 3 pages Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Novelos Therapeutics, Inc
12/34/56